Ignelzi Troy A.

Ignelzi Troy A. is listed in filings as Chief Financial Officer at Rapport Therapeutics, Inc. Common Stock. This profile follows SEC Form 4 activity through Apr 6, 2026, including purchase activity. Recent filings connect the profile to Rapport Therapeutics, Inc. Common Stock (RAPP), Harmony Biosciences Holdings, Inc. (HRMY), and Contineum Therapeutics, Inc. Class A Common Stock (CTNM). The current snapshot covers public activity from Feb 4, 2025 to Apr 6, 2026. Reported amounts are shown as $2.4M to $998. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.